Association between prenatal antibiotic exposure and autism spectrum disorder among term births: A population-based

Amanda S Nitschke1, Helena Abreu do Valle2, Bruce A Vallance3

  • 1School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Prenatal antibiotic exposure showed a small increased risk for autism spectrum disorder (ASD) in offspring. However, these findings should not alter clinical decisions on antibiotic use during pregnancy due to potential confounding.

Area of Science:

  • Investigates the intersection of maternal health, microbiome research, and neurodevelopmental outcomes.
  • Focuses on the impact of environmental factors during pregnancy on child health.
  • Contributes to understanding the microbiome-gut-brain axis in early development.

Background:

  • Prenatal antibiotic exposure can alter the maternal microbiome.
  • Maternal microbiome changes may influence infant microbiome-gut-brain axis development.
  • This pathway could potentially impact neurodevelopmental outcomes like autism spectrum disorder (ASD).

Purpose of the Study:

  • To assess the association between prenatal antibiotic exposure and the risk of autism spectrum disorder (ASD) in term infants.
  • To investigate specific exposure windows (trimesters, duration) and antibiotic classes.
  • To control for potential genetic and environmental confounding factors.

Main Methods:

  • Population-based retrospective cohort study in British Columbia, Canada (2000-2014).
  • Exposure: antibiotic prescriptions filled during pregnancy.
  • Outcome: ASD diagnosis. Analyzed using Cox proportional hazards models and conditional logistic regression in sibling pairs.

Main Results:

  • Prenatal antibiotic exposure was associated with a 10% increased risk of ASD (HR 1.10).
  • Increased risk observed particularly with first/second trimester exposure and longer durations (≥15 days).
  • Association was attenuated in sibling analysis, suggesting residual confounding.

Conclusions:

  • A small increase in ASD risk is associated with prenatal antibiotic exposure.
  • The study highlights the need for careful consideration of antibiotic use during pregnancy.
  • Results should not guide clinical decisions due to potential residual confounding.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
177
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
135